RANI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 53.30%

Insider Buying (Last 12 Months): $49,967.44

Insider Selling (Last 12 Months): $10,147,804.00

Rani Therapeutics Insider Trading History Chart

Rani Therapeutics Share Price & Price History

^$1.08

▲ +0.01 (0.93%)

As of 05/2/2025 05:00 PM ET

Days: 30 | 90 | 365

Rani Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/13/2024	Kate Mckinley	Insider	Buy	17,960	$1.67	$29,993.20	17,960
12/9/2024	Talat Imran	CEO	Buy	10,296	$1.94	$19,974.24	494,751
10/15/2024	South Cone Investments Limited	Major Shareholder	Sell	3,829,360	$2.65	$10,147,804.00	8,302,194
12/6/2023	Talat Imran	CEO	Buy	10,000	$2.27	$22,700.00	484,455
12/4/2023	Talat Imran	CEO	Buy	5,000	$2.57	$12,850.00	474,455
11/29/2023	Talat Imran	CEO	Buy	20,000	$2.05	$41,000.00	469,455
11/24/2023	Cortes Isidoro Alfonso Quiroga	Major Shareholder	Sell	5,265,165	$2.01	$10,582,981.65	8,400
11/16/2023	Maulik Nanavaty	Director	Buy	500	$1.98	$990.00	500
5/11/2023	South Cone Investments Limited	Major Shareholder	Buy	2,610	$3.87	$10,100.70	6,863,744
5/8/2023	South Cone Investments Limited	Major Shareholder	Buy	4,420	$4.46	$19,713.20	6,861,134
5/3/2023	South Cone Investments Limited	Major Shareholder	Buy	2,040	$4.81	$9,812.40	6,856,714
4/28/2023	South Cone Investments Limited	Major Shareholder	Buy	2,173	$4.71	$10,234.83	6,854,674
4/24/2023	South Cone Investments Limited	Major Shareholder	Buy	4,280	$4.67	$19,987.60	6,848,078
4/20/2023	South Cone Investments Limited	Major Shareholder	Buy	1,850	$5.32	$9,842.00	6,839,698
4/18/2023	South Cone Investments Limited	Major Shareholder	Buy	1,850	$5.37	$9,934.50	6,837,848
4/14/2023	South Cone Investments Limited	Major Shareholder	Buy	1,901	$5.27	$10,018.27	6,835,998
4/12/2023	South Cone Investments Limited	Major Shareholder	Buy	3,577	$5.48	$19,601.96	6,833,207
4/10/2023	South Cone Investments Limited	Major Shareholder	Buy	1,923	$5.07	$9,749.61	6,827,865
4/5/2023	South Cone Investments Limited	Major Shareholder	Buy	7,280	$5.49	$39,967.20	6,818,391
4/3/2023	South Cone Investments Limited	Major Shareholder	Buy	3,587	$5.23	$18,760.01	6,806,695
3/30/2023	South Cone Investments Limited	Major Shareholder	Buy	12,230	$4.79	$58,581.70	6,802,357
3/28/2023	South Cone Investments Limited	Major Shareholder	Buy	3,510	$5.49	$19,269.90	6,790,127
3/20/2023	South Cone Investments Limited	Major Shareholder	Buy	532	$6.29	$3,346.28	6,783,387
3/16/2023	South Cone Investments Limited	Major Shareholder	Buy	1,325	$6.07	$8,042.75	6,779,875
3/13/2023	South Cone Investments Limited	Major Shareholder	Buy	2,463	$6.14	$15,122.82	6,778,550
3/8/2023	South Cone Investments Limited	Major Shareholder	Buy	1,702	$6.58	$11,199.16	6,772,357
3/6/2023	South Cone Investments Limited	Major Shareholder	Buy	1,100	$6.39	$7,029.00	6,770,655
3/2/2023	South Cone Investments Limited	Major Shareholder	Buy	3,900	$6.31	$24,609.00	6,769,555
2/27/2023	South Cone Investments Limited	Major Shareholder	Buy	3,541	$6.30	$22,308.30	6,764,944
2/24/2023	South Cone Investments Limited	Major Shareholder	Buy	5,451	$6.09	$33,196.59	6,761,403
2/21/2023	South Cone Investments Limited	Major Shareholder	Buy	3,080	$5.94	$18,295.20	6,754,952
2/16/2023	South Cone Investments Limited	Major Shareholder	Buy	9,500	$5.49	$52,155.00	6,743,404
2/14/2023	South Cone Investments Limited	Major Shareholder	Buy	9,250	$5.25	$48,562.50	6,723,904
12/28/2022	South Cone Investments Limited	Major Shareholder	Buy	9,157	$5.58	$51,096.06	6,697,454
12/19/2022	South Cone Investments Limited	Major Shareholder	Buy	6,900	$7.43	$51,267.00	6,688,297
12/16/2022	South Cone Investments Limited	Major Shareholder	Buy	6,400	$7.76	$49,664.00	6,681,397
12/12/2022	South Cone Investments Limited	Major Shareholder	Buy	12,500	$8.04	$100,500.00	6,646,628
12/9/2022	South Cone Investments Limited	Major Shareholder	Buy	12,345	$8.01	$98,883.45	6,634,128
12/7/2022	South Cone Investments Limited	Major Shareholder	Buy	600	$7.94	$4,764.00	6,609,588
12/5/2022	South Cone Investments Limited	Major Shareholder	Buy	12,195	$7.97	$97,194.15	6,596,488
12/2/2022	South Cone Investments Limited	Major Shareholder	Buy	9,819	$8.16	$80,123.04	6,584,293
11/30/2022	South Cone Investments Limited	Major Shareholder	Buy	8,000	$7.93	$63,440.00	6,574,272
11/28/2022	South Cone Investments Limited	Major Shareholder	Buy	3,720	$7.95	$29,574.00	6,566,272
11/25/2022	South Cone Investments Limited	Major Shareholder	Buy	800	$7.84	$6,272.00	6,562,552
11/23/2022	South Cone Investments Limited	Major Shareholder	Buy	3,396	$7.84	$26,624.64	6,561,752
11/21/2022	South Cone Investments Limited	Major Shareholder	Buy	3,200	$7.87	$25,184.00	6,545,856
11/18/2022	South Cone Investments Limited	Major Shareholder	Buy	13,300	$7.49	$99,617.00	6,542,656
11/2/2022	Cortes Isidoro Alfonso Quiroga	Major Shareholder	Buy	25,197	$6.31	$158,993.07	5,247,786
10/31/2022	Cortes Isidoro Alfonso Quiroga	Major Shareholder	Buy	16,523	$6.11	$100,955.53	5,218,821
8/17/2022	Mir A Imran	Director	Sell	80,252	$10.64	$853,881.28	66,445

See Full Table

SEC Filings (Institutional Ownership Changes) for Rani Therapeutics (NASDAQ:RANI)

30.19% of Rani Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Rani Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/21/2025	CWA Asset Management Group LLC	83,333	$0.11M	0.0%	N/A	0.145%
2/17/2025	Two Sigma Advisers LP	110,163	$0.15M	0.0%	N/A	0.192%
2/17/2025	Two Sigma Investments LP	291,381	$0.40M	0.0%	N/A	0.509%
2/17/2025	Bridgeway Capital Management LLC	56,500	$77K	0.0%	-21.0%	0.099%
2/13/2025	Insigneo Advisory Services LLC	47,500	$65K	0.0%	N/A	0.083%
2/12/2025	Takeda Pharmaceutical Co. Ltd.	203,190	$0.28M	1.0%	N/A	0.355%
2/11/2025	Virtu Financial LLC	45,404	$62K	0.0%	N/A	0.079%
2/7/2025	King Luther Capital Management Corp	33,000	$45K	0.0%	-59.3%	0.058%
1/17/2025	Janney Montgomery Scott LLC	27,200	$37K	0.0%	N/A	0.047%
11/16/2024	Geode Capital Management LLC	172,261	$0.37M	0.0%	+14.3%	0.323%
11/15/2024	United Services Automobile Association	302,743	$0.65M	0.0%	-3.0%	0.567%
11/15/2024	Stifel Financial Corp	269,768	$0.58M	0.0%	+100.4%	0.505%
11/8/2024	King Luther Capital Management Corp	81,129	$0.18M	0.0%	+44.5%	0.152%
8/14/2024	Marshall Wace LLP	21,247	$81K	0.0%	N/A	0.042%
8/9/2024	Renaissance Technologies LLC	21,700	$82K	0.0%	-69.1%	0.043%
8/7/2024	United Services Automobile Association	312,095	$1.19M	0.0%	-35.2%	0.619%
5/10/2024	Vanguard Group Inc.	685,303	$2.13M	0.0%	+2.5%	1.366%
2/14/2024	Alpha Square Group S LLC	58,946	$0.20M	0.2%	-32.2%	0.118%
8/10/2023	King Luther Capital Management Corp	56,129	$0.23M	0.0%	N/A	0.113%
8/4/2023	Choreo LLC	19,813	$82K	0.0%	-20.2%	0.040%
5/11/2023	Icon Wealth Partners LLC	12,757	$66K	0.0%	N/A	0.026%
5/11/2023	Alphabet Inc.	448,492	$2.31M	0.1%	-12.1%	0.908%
2/8/2023	Prime Capital Investment Advisors LLC	33,502	$0.20M	0.0%	N/A	0.068%
11/18/2022	TPB Wealth Advisors	48,129	$0.46M	0.2%	-33.0%	0.098%
11/16/2022	Alphabet Inc.	714,471	$6.85M	0.3%	N/A	1.453%
11/3/2022	Motco	48,129	$0.46M	0.0%	N/A	0.098%
10/28/2022	Lafayette Investments Inc.	19,893	$0.19M	0.1%	N/A	0.040%
10/17/2022	Canton Hathaway LLC	16,200	$0.16M	0.1%	+88.4%	0.033%
10/14/2022	Iowa State Bank	18,862	$0.18M	0.1%	N/A	0.038%
8/8/2022	Islay Capital Management LLC	9,611	$99K	0.1%	N/A	0.020%
8/8/2022	Crossvault Capital Management LLC	14,285	$0.15M	0.1%	N/A	0.029%
7/29/2022	Aspireon Wealth Advisors	71,811	$0.74M	0.3%	N/A	0.146%
7/20/2022	Canton Hathaway LLC	8,600	$89K	0.0%	N/A	0.017%
6/15/2022	Lasry Marc	62,828	$0.85M	0.4%	N/A	0.128%
5/17/2022	Lasry Marc	62,828	$0.85M	0.4%	N/A	0.128%
5/13/2022	United Services Automobile Association	481,300	$6.50M	0.1%	N/A	0.979%
2/3/2022	Advisor Group Holdings Inc.	21,072	$0.34M	0.0%	N/A	0.043%
1/6/2022	Canton Hathaway LLC	5,000	$82K	0.0%	-50.0%	0.010%
11/16/2021	Squarepoint Ops LLC	50,000	$0.89M	0.0%	N/A	0.102%
11/15/2021	Caas Capital Management LP	75,000	$1.34M	0.0%	N/A	0.153%
11/10/2021	Goldman Sachs Group Inc.	60,649	$1.08M	0.0%	N/A	0.124%

Data available starting January 2016

See Full Table

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.

Today's Range

Now: $1.08

$1.05

$1.11

50 Day Range

MA: $1.31

$1.06

$1.58

52 Week Range

Now: $1.08

$1.02

$7.88

Volume

177,831 shs

Average Volume

744,397 shs

Market Capitalization

$62.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24

Who are the company insiders with the largest holdings of Rani Therapeutics?: Rani Therapeutics' top insider shareholders include:
South Cone Investments Limited (Major Shareholder)
Talat Imran (CEO)
Kate Mckinley (Insider)
Cortes Isidoro Alfonso Quiroga (Major Shareholder)
Maulik Nanavaty (Director)
Learn More about top insider investors at Rani Therapeutics.
Who are the major institutional investors of Rani Therapeutics?: Rani Therapeutics' top institutional investors include:
CWA Asset Management Group LLC — 0.14%
Learn More about top institutional investors of Rani Therapeutics stock.
Which major investors are buying Rani Therapeutics stock?: During the last quarter, RANI stock was bought by institutional investors including:
CWA Asset Management Group LLC
During the last year, these company insiders have bought Rani Therapeutics stock:
South Cone Investments Limited (Major Shareholder)
Talat Imran (CEO)
Kate Mckinley (Insider)
Cortes Isidoro Alfonso Quiroga (Major Shareholder)
Learn More investors buying Rani Therapeutics stock.